Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT20201126049498N2Phase 3Completed
Phase 3, double-blind trial of diclofenac in knee osteoarthritis (OA) (2 arms), sponsored by Shahed University. Primary endpoints: Erythrocyte sedimentation rate, C-reactive protein and 7 more. Started Mar 2021; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT20201126049498N2.